CompletedNot applicableNCT03339245

Effects of Dietary Fructose on Gut Microbiota and Fecal Metabolites in Obese Men and Postmenopausal Women: A Pilot Study

Studying NON RARE IN EUROPE: Non-alcoholic fatty liver disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Rockefeller University
Principal Investigator
Peter Holt, MD
Rockefeller University
Intervention
Fructose Solution (75 Grams)(other)
Enrollment
13 enrolled
Eligibility
45-70 years · All sexes
Timeline
20172018

Study locations (1)

Collaborators

Weill Medical College of Cornell University · National Institutes of Health (NIH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03339245 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Non-alcoholic fatty liver disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Non-alcoholic fatty liver disease

← Back to all trials